stars 1 stars 2 stars 3

dRx Capital backs exceptional entrepreneurs transforming healthcare through data and digital technology. The fund, backed by Novartis, invests in technology platforms improving access to healthcare and reimagining the practice of medicine, with a focus on AI & ML, big data, R&D optimization, patient care, and pharma supply chain and commercialization. dRx Capital currently has 20 portfolio companies, including: Aktana, Animantis, Aspen RxHealth, Cala Health, Cota Health, Flywheel, Freenome, H1, Koneksa, Mekonos, NuvoAir, Omada, Pear Therapeutics, Peptone, RxVantage, SchoolCare, Science 37, SomaLogic, Vineti, Xealth.

View Top Employees from dRx Capital
Website https://drxcapital.com/
Revenue $4 million
Employees 7 (3 on RocketReach)
Founded 2015
Phone +41 61 324 11 11
Technologies
Industry Venture Capital and Private Equity Principals, Finance General, Financial Services, Venture Capital, Finance, Digital Health, Digital Medicine
Competitors AVIA, Aging2.0, GV (Google Ventures), Jumpstart Foundry, Kleiner Perkins
SIC SIC Code 679 Companies, SIC Code 67 Companies
NAICS NAICS Code 5239 Companies, NAICS Code 52 Companies, NAICS Code 523 Companies

dRx Capital Questions

The dRx Capital annual revenue was $4 million in 2024.

Rishabh Mehreja is the Managing Director of dRx Capital.

3 people are employed at dRx Capital.

The NAICS codes for dRx Capital are [5239, 52, 523].

The SIC codes for dRx Capital are [679, 67].

Top dRx Capital Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users